What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Surgery, Internal medicine, Ovarian cancer, Cancer research and Chemotherapy.
His Surgery research includes elements of Cervical cancer and Lymphadenectomy.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology.
His study looks at the relationship between Oncology and topics such as Pathology, which overlap with Antigen.
His Ovarian cancer research focuses on Paclitaxel and how it connects with Tubulin.
Giovanni Scambia has included themes like Immunohistochemistry, Immunology, Carcinogenesis, Estrogen receptor and Cell cycle in his Cancer research study.
His most cited work include:
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial (989 citations)
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas (766 citations)
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial (640 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Surgery, Ovarian cancer, Oncology and Chemotherapy are his primary areas of study.
His Internal medicine research includes elements of Gastroenterology and Endocrinology.
As a member of one scientific family, Giovanni Scambia mostly works in the field of Surgery, focusing on Cervical cancer and, on occasion, Radical surgery.
His Ovarian cancer research incorporates elements of Cancer research, Paclitaxel, Disease and Ovary.
His study in Oncology is interdisciplinary in nature, drawing from both Breast cancer, Carcinoma, Advanced ovarian cancer and Retrospective cohort study.
His Stage study frequently links to related topics such as Radiology.
He most often published in these fields:
- Internal medicine (36.80%)
- Surgery (27.67%)
- Ovarian cancer (24.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (36.80%)
- Surgery (27.67%)
- Oncology (22.30%)
In recent papers he was focusing on the following fields of study:
Giovanni Scambia mainly focuses on Internal medicine, Surgery, Oncology, Ovarian cancer and Radiology.
His work on Chemotherapy, Bevacizumab and Progression-free survival as part of his general Internal medicine study is frequently connected to Olaparib, thereby bridging the divide between different branches of science.
His study focuses on the intersection of Surgery and fields such as Cervical cancer with connections in the field of Radical surgery.
His Oncology study incorporates themes from BRCA mutation, Phases of clinical research, Newly diagnosed and Recurrent Ovarian Carcinoma, Recurrent Ovarian Cancer.
Giovanni Scambia combines subjects such as Cancer research and Disease with his study of Ovarian cancer.
His work in Radiology addresses subjects such as Sentinel lymph node, which are connected to disciplines such as Lymphadenectomy and Endometrial cancer.
Between 2018 and 2021, his most popular works were:
- Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. (312 citations)
- Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women. (67 citations)
- Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women. (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Giovanni Scambia spends much of his time researching Internal medicine, Ovarian cancer, Surgery, Oncology and Stage.
Giovanni Scambia undertakes interdisciplinary study in the fields of Internal medicine and Olaparib through his works.
His research integrates issues of Gemcitabine, Chemotherapy, Cancer research and Serous fluid in his study of Ovarian cancer.
Giovanni Scambia studied Surgery and Debulking that intersect with Fallopian tube, Survival analysis and Laparotomy.
His Oncology research incorporates themes from Phases of clinical research, Newly diagnosed, Standard treatment, Personalized medicine and Bevacizumab.
His research investigates the connection between Stage and topics such as Cervical cancer that intersect with problems in Radical surgery, Chemoradiotherapy, Cervix, Adenocarcinoma and Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
